The largest purchase of all time was on 2017-09-15 and amounted to 60000 shares of Lexicon Pharmaceuticals, Inc. for $752,866.
The largest sale of all time was on 2019-08-15 and amounted to 20000 shares of Blueprint Medicines Corporation for $1.65M.
No biography is available at this moment.
| 2023-11-16 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 90,000 0.0365% | $1.05 | $94,797 | +62.26% | ||
| 2023-11-10 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 10,000 0.0041% | $1.01 | $10,100 | +69.37% | ||
| 2023-06-29 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 10,000 0.0053% | $2.16 | $21,600 | -21.43% | ||
| 2023-06-26 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 10,000 0.0053% | $2.18 | $21,792 | -21.2% | ||
| 2023-06-23 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 10,000 0.0056% | $2.50 | $24,950 | -27.85% | ||
| 2023-06-22 | Lexicon Pharmaceuticals, Inc. LXRX | Chief Executive Officer | 40,000 0.0211% | $2.31 | $92,400 | -26.08% | ||
| 2019-09-18 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 100,000 0.0768% | $3.10 | $310,000 | -42.37% | ||
| 2019-09-17 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 100,000 0.1001% | $3.13 | $312,806 | -24.83% | ||
| 2019-08-19 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 6,000 0.0056% | $1.40 | $8,388 | +60.99% | ||
| 2019-08-16 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 74,000 0.0685% | $1.35 | $99,669 | +67.88% | ||
| 2019-08-15 | Sale | Blueprint Medicines Corporation BPMC | director | 20,000 0.0412% | $82.40 | $1.65M | -10.05% | |
| 2017-11-15 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 20,000 0.0185% | $9.91 | $198,200 | -1.67% | ||
| 2017-09-15 | Lexicon Pharmaceuticals, Inc. LXRX | President and CEO | 60,000 0.0576% | $12.55 | $752,866 | -17.22% |